IPO - INTELLIGENT BIO SOLUTIONS INC.

Form Type: 424B5

Filing Date: 2025-02-21

Corporate Action: Ipo

Type: New

Accession Number: 000149315225007778

Filing Summary: Intelligent Bio Solutions Inc. is conducting a public offering of 1,304,348 shares of its common stock at a public offering price of $2.00 per share. Following the offering, the total value is expected to be approximately $2.6 million before underwriting discounts and commissions. The company reported a last sale price of $2.48 on February 18, 2025, on The Nasdaq Capital Market under the symbol 'INBS'. The offering is part of General Instruction I.B.6 of Form S-3 regarding public offerings of securities, as the company maintains a public float below $75 million, and it has previously sold $1.5 million in shares under these guidelines. The proceeds from this offering will be utilized for general corporate purposes and working capital. The company granted the underwriters an overallotment option to purchase an additional 195,652 shares. This offering is subject to market conditions and closing conditions, with the expected delivery date set for February 21, 2025. The company has been authorized to utilize certain exemptions regarding financial reporting and oversight, as it is classified as an emerging growth company.

Document Link: View Document

Form Type: 8-K

Filing Date: 2025-02-21

Corporate Action: Ipo

Type: New

Accession Number: 000149315225007928

Filing Summary: On February 21, 2025, Intelligent Bio Solutions Inc. completed an underwritten public offering of 1,304,348 shares of its common stock at a public offering price of $2.00 per share, totaling gross proceeds of $3.0 million before expenses. The offering included a 45-day over-allotment option, which the underwriters fully exercised, adding 195,652 shares. The company plans to use the net proceeds for working capital and general corporate purposes. The offering was made under an effective shelf registration statement on Form S-3 declared effective on April 20, 2022. The underwriters received an 8.0% discount on the offering, and the company also issued warrants to the underwriters to purchase 75,000 shares at an exercise price of $2.50 per share, expiring February 20, 2030. The document includes several press releases announcing the launch, pricing, and closing of the offering.

Document Link: View Document

Form Type: 424B5

Filing Date: 2025-02-19

Corporate Action: Ipo

Type: New

Accession Number: 000149315225007568

Filing Summary: Intelligent Bio Solutions Inc. is conducting a firm commitment underwritten public offering of common stock, aiming for the sale of shares to raise capital. As of February 18, 2025, the trading price of the common stock was reported at $2.48 per share. The company is categorized as an 'emerging growth company' which allows it reduced disclosure obligations. The prospectus stipulates that the underwriters have a 45-day option to purchase additional shares to cover overallotments. The anticipated completion date of share delivery is forthcoming, subject to closing conditions. Alongside the offering proceeds, the company has disclosed a recent submission for FDA clearance of its Intelligent Fingerprinting Drug Screening System, marking a key recent development.

Document Link: View Document